November 11, 2025 · Form 4 insider transaction
BROSHY ERAN sold 29,500 shares of Theravance Biopharma, Inc. at $18.50 per share, a transaction worth $545.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024.